http://fdanews.com/newsletter/article?issueId=10753&articleId=98762
quote:
The firm said it recently has invested more than $2 billion to expand its manufacturing capacity for the vaccines, as well as for capacity of its inhaled antiviral flu treatment Relenza (zanamivir).
end quote:
- Forums
- ASX - By Stock
- gsk increasing amount of flu vaccine
http://fdanews.com/newsletter/article?issueId=10753&articleId=987...
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online